Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
12.59
+0.04 (0.32%)
At close: Sep 12, 2025, 4:00 PM EDT
12.49
-0.10 (-0.79%)
After-hours: Sep 12, 2025, 4:10 PM EDT
Crescent Biopharma Market Cap
Crescent Biopharma has a market cap or net worth of $246.13 million as of September 12, 2025.
Market Cap
246.13M
Enterprise Value
246.89M
1-Year Change
n/a
Ranking
Category
Stock Price
$12.59
Market Cap Chart
Since June 16, 2025, Crescent Biopharma's market cap has decreased from $308.79M to $246.13M, a decrease of -20.29%. That is a compound annual growth rate of -60.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 244.18M | -0.48% |
| Sep 11, 2025 | 245.35M | 2.62% |
| Sep 10, 2025 | 239.09M | -2.55% |
| Sep 9, 2025 | 245.35M | -3.09% |
| Sep 8, 2025 | 253.17M | -9.06% |
| Sep 5, 2025 | 278.39M | 4.02% |
| Sep 4, 2025 | 267.64M | 3.48% |
| Sep 3, 2025 | 258.64M | -3.29% |
| Sep 2, 2025 | 267.44M | -5.00% |
| Aug 29, 2025 | 281.52M | 1.77% |
| Aug 28, 2025 | 276.63M | -0.70% |
| Aug 27, 2025 | 278.58M | -1.52% |
| Aug 26, 2025 | 282.88M | -1.56% |
| Aug 25, 2025 | 287.38M | -2.39% |
| Aug 22, 2025 | 294.42M | 4.58% |
| Aug 21, 2025 | 281.52M | 4.35% |
| Aug 20, 2025 | 269.79M | 1.47% |
| Aug 19, 2025 | 265.88M | -1.38% |
| Aug 18, 2025 | 269.59M | - |
| Aug 15, 2025 | 269.59M | -1.01% |
| Aug 14, 2025 | 272.33M | 0.22% |
| Aug 13, 2025 | 271.74M | 7.09% |
| Aug 12, 2025 | 253.75M | 0.62% |
| Aug 11, 2025 | 252.19M | 0.39% |
| Aug 8, 2025 | 251.21M | 16.82% |
| Aug 7, 2025 | 215.05M | - |
| Aug 6, 2025 | 215.05M | -5.17% |
| Aug 5, 2025 | 226.78M | -2.03% |
| Aug 4, 2025 | 231.47M | -1.33% |
| Aug 1, 2025 | 234.60M | -3.38% |
| Jul 31, 2025 | 242.81M | -1.43% |
| Jul 30, 2025 | 246.33M | 2.44% |
| Jul 29, 2025 | 240.46M | -7.17% |
| Jul 28, 2025 | 259.03M | -0.30% |
| Jul 25, 2025 | 259.82M | 2.07% |
| Jul 24, 2025 | 254.54M | -1.21% |
| Jul 23, 2025 | 257.66M | 1.07% |
| Jul 22, 2025 | 254.93M | -1.21% |
| Jul 21, 2025 | 258.06M | -1.05% |
| Jul 18, 2025 | 260.79M | 2.46% |
| Jul 17, 2025 | 254.54M | -0.91% |
| Jul 16, 2025 | 256.88M | 11.88% |
| Jul 15, 2025 | 229.61M | -8.24% |
| Jul 14, 2025 | 250.24M | -1.23% |
| Jul 11, 2025 | 253.36M | -4.00% |
| Jul 10, 2025 | 263.92M | -8.72% |
| Jul 9, 2025 | 289.14M | -1.99% |
| Jul 8, 2025 | 295.00M | -1.31% |
| Jul 7, 2025 | 298.91M | -3.78% |
| Jul 3, 2025 | 310.64M | 2.22% |
| Jul 2, 2025 | 303.90M | -3.75% |
| Jul 1, 2025 | 315.73M | 0.06% |
| Jun 30, 2025 | 315.53M | 1.51% |
| Jun 27, 2025 | 310.84M | -5.92% |
| Jun 26, 2025 | 330.39M | -6.11% |
| Jun 25, 2025 | 351.89M | 19.48% |
| Jun 24, 2025 | 294.52M | -1.54% |
| Jun 23, 2025 | 299.11M | 2.00% |
| Jun 20, 2025 | 293.25M | 2.60% |
| Jun 18, 2025 | 285.82M | 10.17% |
| Jun 17, 2025 | 259.42M | -15.99% |
| Jun 16, 2025 | 308.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.18B |
| Johnson & Johnson | 429.82B |
| AbbVie | 390.87B |
| UnitedHealth Group | 322.09B |
| AstraZeneca | 251.66B |
| Novartis AG | 244.56B |
| Novo Nordisk | 241.70B |
| Abbott Laboratories | 230.73B |